Demonstration of mixed properties of RU486 in progesterone receptor (PR)-transfected MDA-MB-231 cells: a model for studying the functions of progesterone analogues

Progesterone antagonist RU486 (mifepristone) has been implicated for many anti-neoplastic and obstetrical applications. But the compound has demonstrated undesired agonist-like effect depending on cell, tissue and species studied. Using PR-transfected breast cancer cells MDA-MB-231, this report desc...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Lin, V C-L, Aw, S E, Ng, E H, Ng, E H-L, Tan, M G-K
Médium: Artigo
Jazyk:Inglês
Vydáno: Nature Publishing Group 2001
Témata:
Regular Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2364017/
https://ncbi.nlm.nih.gov/pubmed/11747343
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1054/bjoc.2001.2167
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky